Advertisement

Index by author

April 01, 1988; Volume 245,Issue 1

A

  1. Abhold, R H

    1. Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain.
      R H Abhold and J W Harding
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 171-177;

  2. Abiko, Y

    1. MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
      Y Hara, K Ichihara and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 305-310;

  3. Adams, L M

    1. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.
      T J Rimele, R J Sturm, L M Adams, D E Henry, R J Heaslip, B M Weichman and D Grimes
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 102-111;

  4. Alaranta, S

    1. Pharmacological analysis of nicotinic relaxation of bovine retractor penis muscle.
      E Klinge, S Alaranta and N O Sjöstrand
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 280-286;

  5. Albrightson-Winslow, C R

    1. SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).
      D P Brooks, P F Koster, C R Albrightson-Winslow, F L Stassen, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 211-215;

  6. Ali, S F

    1. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
      G E Schulze, D E McMillan, J R Bailey, A Scallet, S F Ali, W Slikker and M G Paule
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 178-186;

  7. Araki, Y

    1. Increment of calmodulin in proportion to enhancement of non-nicotinic responses after preganglionic stimulation of the dog cardiac sympathetic ganglia.
      K Kushiku, Y Araki, T Furukawa, T Iwasa, N Inoue and E Miyamoto
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 311-318;

B

  1. Baba, A

    1. Mechanism of excitatory amino acid-induced accumulation of cyclic AMP in hippocampal slices: role of extracellular chloride.
      A Baba, Y Nishiuchi, A Uemura and H Iwata
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 299-304;

  2. Bache, R J

    1. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
      R J Bache, D C Homans, J S Schwartz and X Z Dai
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 232-237;

  3. Bailey, J R

    1. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
      G E Schulze, D E McMillan, J R Bailey, A Scallet, S F Ali, W Slikker and M G Paule
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 178-186;

  4. Bergman, J

    1. Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys.
      L L Howell, J Bergman and W H Morse
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 364-372;

  5. Bhaskaran, D

    1. Changes in arterial blood pressure lead to baroreceptor-mediated changes in norepinephrine and 5-hydroxyindoleacetic acid in rat nucleus tractus solitarius.
      D Bhaskaran and C R Freed
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 356-363;

  6. Biggar, W D

    1. Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells.
      J Uetrecht, N Zahid, N H Shear and W D Biggar
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 274-279;

  7. Bodnar, R J

    1. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
      C L Williams, R J Bodnar, J E Clark, E F Hahn, T F Burks and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 8-12;

  8. Brase, D A

    1. Differential effects of subcutaneous and intrathecal morphine administration on blood glucose in mice: comparison with intracerebroventricular administration.
      F Lux, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 187-194;

  9. Brooks, D P

    1. SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).
      D P Brooks, P F Koster, C R Albrightson-Winslow, F L Stassen, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 211-215;

  10. Brown, M J

    1. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
      D Harland and M J Brown
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 265-273;

  11. Bucchi, F

    1. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
      M C Gambino, S Passaghe, Z M Chen, F Bucchi, G Gori, R Latini, G de Gaetano and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 287-290;

  12. Burks, T F

    1. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
      J S Heyman, C L Williams, T F Burks, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 238-243;
    2. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
      C L Williams, R J Bodnar, J E Clark, E F Hahn, T F Burks and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 8-12;

C

  1. Callaham, M

    1. Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning.
      M Callaham, H Schumaker and P Pentel
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 216-220;

  2. Cerletti, C

    1. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
      M C Gambino, S Passaghe, Z M Chen, F Bucchi, G Gori, R Latini, G de Gaetano and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 287-290;

  3. Cervenko, F W

    1. Tolerance to intrathecal oxymetazoline-induced analgesia, with paradigm-dependent cross-tolerance to intrathecal morphine.
      S E Sherman, C W Loomis, B Milne and F W Cervenko
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 319-326;

  4. Chandrasekhar, R

    1. Alterations in rat brain polyphosphoinositide metabolism due to acute ethanol administration.
      R Chandrasekhar, H M Huang and G Y Sun
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 120-123;

  5. Chapnick, B M

    1. Relationship between LTD4-induced endothelium-dependent vasomotor relaxation and cGMP.
      R J Secrest, E H Ohlstein and B M Chapnick
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 47-52;

  6. Chen, Z M

    1. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
      M C Gambino, S Passaghe, Z M Chen, F Bucchi, G Gori, R Latini, G de Gaetano and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 287-290;

  7. Clark, J E

    1. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
      C L Williams, R J Bodnar, J E Clark, E F Hahn, T F Burks and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 8-12;

  8. Clineschmidt, B V

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

  9. Cooper, B R

    1. Use of conditioned taste aversion as a conflict model: effects of anxiolytic drugs.
      G N Ervin and B R Cooper
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 137-146;

  10. Coulombe, P R

    1. Further evidence for a homogeneous population of beta-1-adrenoceptors in bovine coronary artery.
      R E Purdy, G L Stupecky and P R Coulombe
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 67-71;

  11. Cubeddu, L X

    1. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
      E M Parker and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 199-210;

D

  1. Dai, X Z

    1. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
      R J Bache, D C Homans, J S Schwartz and X Z Dai
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 232-237;

  2. Daniell, L C

    1. Neuronal intracellular calcium concentrations are altered by anesthetics: relationship to membrane fluidization.
      L C Daniell and R A Harris
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 1-7;

  3. Danilo, P

    1. Reduction of Vmax by QX-314 and benzocaine in neonatal and adult canine cardiac Purkinje fibers.
      W Spinelli, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 381-387;

  4. Da Silva, A M

    1. Central nervous system site of action for the hypotensive effect of clonidine in the cat.
      P J Gatti, K J Hill, A M Da Silva, W P Norman and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 373-380;

  5. de Gaetano, G

    1. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
      M C Gambino, S Passaghe, Z M Chen, F Bucchi, G Gori, R Latini, G de Gaetano and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 287-290;

  6. Dewey, W L

    1. Differential effects of subcutaneous and intrathecal morphine administration on blood glucose in mice: comparison with intracerebroventricular administration.
      F Lux, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 187-194;

  7. Di Chiara, G

    1. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
      A Imperato, G Tanda, R Frau and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 257-264;

  8. Donohue, S J

    1. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats.
      S J Donohue, R E Stitzel and R J Head
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 24-31;

E

  1. Effeney, D J

    1. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
      S M Pond, J A Waschek, V Mahacha, R M Fielding, D J Effeney and T N Tozer
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 291-293;

  2. Eisenhofer, G

    1. Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 81-88;

  3. Emmett-Oglesby, M W

    1. Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine.
      M W Emmett-Oglesby, T S Shippenberg and A Herz
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 17-23;

  4. Ervin, G N

    1. Use of conditioned taste aversion as a conflict model: effects of anxiolytic drugs.
      G N Ervin and B R Cooper
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 137-146;

F

  1. Fielding, R M

    1. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
      S M Pond, J A Waschek, V Mahacha, R M Fielding, D J Effeney and T N Tozer
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 291-293;

  2. Frau, R

    1. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
      A Imperato, G Tanda, R Frau and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 257-264;

  3. Freed, C R

    1. Changes in arterial blood pressure lead to baroreceptor-mediated changes in norepinephrine and 5-hydroxyindoleacetic acid in rat nucleus tractus solitarius.
      D Bhaskaran and C R Freed
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 356-363;

  4. Fujiwara, M

    1. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
      K Ohno, T Sakai, M Fukushima, S Narumiya and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 294-298;

  5. Fukushima, M

    1. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
      K Ohno, T Sakai, M Fukushima, S Narumiya and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 294-298;

  6. Furukawa, T

    1. Increment of calmodulin in proportion to enhancement of non-nicotinic responses after preganglionic stimulation of the dog cardiac sympathetic ganglia.
      K Kushiku, Y Araki, T Furukawa, T Iwasa, N Inoue and E Miyamoto
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 311-318;

G

  1. Gambino, M C

    1. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
      M C Gambino, S Passaghe, Z M Chen, F Bucchi, G Gori, R Latini, G de Gaetano and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 287-290;

  2. Gatti, P J

    1. Central nervous system site of action for the hypotensive effect of clonidine in the cat.
      P J Gatti, K J Hill, A M Da Silva, W P Norman and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 373-380;

  3. George, F R

    1. Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains.
      T Suzuki, F R George and R A Meisch
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 164-170;

  4. Gillis, R A

    1. Central nervous system site of action for the hypotensive effect of clonidine in the cat.
      P J Gatti, K J Hill, A M Da Silva, W P Norman and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 373-380;

  5. Goldstein, D S

    1. Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 81-88;

  6. Gori, G

    1. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
      M C Gambino, S Passaghe, Z M Chen, F Bucchi, G Gori, R Latini, G de Gaetano and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 287-290;

  7. Grider, J R

    1. Identification of separate bombesin and substance P receptors on isolated muscle cells from canine gallbladder.
      C Severi, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 195-198;

  8. Grimes, D

    1. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.
      T J Rimele, R J Sturm, L M Adams, D E Henry, R J Heaslip, B M Weichman and D Grimes
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 102-111;

  9. Guild, S

    1. Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population.
      T Reisine, H L Wang and S Guild
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 225-231;

H

  1. Hahn, E F

    1. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
      C L Williams, R J Bodnar, J E Clark, E F Hahn, T F Burks and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 8-12;

  2. Hanada, S

    1. Benzodiazepines and barbiturate potentiate the pre- and postsynaptic gamma-aminobutyric acid (GABA)A receptor-mediated response in the enteric nervous system of guinea pig small intestine.
      K Taniyama, S Hashimoto, S Hanada and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 250-256;

  3. Hara, Y

    1. MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
      Y Hara, K Ichihara and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 305-310;

  4. Harding, J W

    1. Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain.
      R H Abhold and J W Harding
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 171-177;

  5. Harker, C T

    1. Cooling the central ear artery of the rabbit: myogenic and adrenergic responses.
      C T Harker and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 89-93;

  6. Harland, D

    1. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
      D Harland and M J Brown
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 265-273;

  7. Harris, R A

    1. Neuronal intracellular calcium concentrations are altered by anesthetics: relationship to membrane fluidization.
      L C Daniell and R A Harris
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 1-7;

  8. Hashimoto, S

    1. Benzodiazepines and barbiturate potentiate the pre- and postsynaptic gamma-aminobutyric acid (GABA)A receptor-mediated response in the enteric nervous system of guinea pig small intestine.
      K Taniyama, S Hashimoto, S Hanada and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 250-256;

  9. Head, R J

    1. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats.
      S J Donohue, R E Stitzel and R J Head
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 24-31;

  10. Heaslip, R J

    1. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.
      T J Rimele, R J Sturm, L M Adams, D E Henry, R J Heaslip, B M Weichman and D Grimes
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 102-111;

  11. Helke, C J

    1. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
      C J Helke and E T Phillips
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 41-46;

  12. Henry, D E

    1. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.
      T J Rimele, R J Sturm, L M Adams, D E Henry, R J Heaslip, B M Weichman and D Grimes
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 102-111;

  13. Herz, A

    1. Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine.
      M W Emmett-Oglesby, T S Shippenberg and A Herz
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 17-23;

  14. Heyman, J S

    1. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
      J S Heyman, C L Williams, T F Burks, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 238-243;

  15. Hill, K J

    1. Central nervous system site of action for the hypotensive effect of clonidine in the cat.
      P J Gatti, K J Hill, A M Da Silva, W P Norman and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 373-380;

  16. Homans, D C

    1. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
      R J Bache, D C Homans, J S Schwartz and X Z Dai
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 232-237;

  17. Howell, L L

    1. Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys.
      L L Howell, J Bergman and W H Morse
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 364-372;

  18. Huang, H M

    1. Alterations in rat brain polyphosphoinositide metabolism due to acute ethanol administration.
      R Chandrasekhar, H M Huang and G Y Sun
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 120-123;

  19. Hucker, H B

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

  20. Huff, J R

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

  21. Huffman, W F

    1. SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).
      D P Brooks, P F Koster, C R Albrightson-Winslow, F L Stassen, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 211-215;

I

  1. Ichihara, K

    1. MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
      Y Hara, K Ichihara and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 305-310;

  2. Imperato, A

    1. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
      A Imperato, G Tanda, R Frau and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 257-264;

  3. Inoue, N

    1. Increment of calmodulin in proportion to enhancement of non-nicotinic responses after preganglionic stimulation of the dog cardiac sympathetic ganglia.
      K Kushiku, Y Araki, T Furukawa, T Iwasa, N Inoue and E Miyamoto
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 311-318;

  4. Iwasa, T

    1. Increment of calmodulin in proportion to enhancement of non-nicotinic responses after preganglionic stimulation of the dog cardiac sympathetic ganglia.
      K Kushiku, Y Araki, T Furukawa, T Iwasa, N Inoue and E Miyamoto
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 311-318;

  5. Iwata, H

    1. Mechanism of excitatory amino acid-induced accumulation of cyclic AMP in hippocampal slices: role of extracellular chloride.
      A Baba, Y Nishiuchi, A Uemura and H Iwata
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 299-304;

J

  1. Jaiswal, N

    1. Prostaglandin synthesis elicited by cholinergic stimuli is mediated by activation of M2 muscarinic receptors in rabbit heart.
      N Jaiswal and K U Malik
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 59-66;
    2. 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase.
      B V Sastry, N Jaiswal, L K Owens, V E Janson and R D Moore
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 72-80;

  2. Janson, V E

    1. 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase.
      B V Sastry, N Jaiswal, L K Owens, V E Janson and R D Moore
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 72-80;

  3. Johanson, C E

    1. Sensitization to kappa opioid mechanisms associated with tolerance to the anorectic effects of cathinone.
      P Nencini, C E Johanson and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 147-154;

K

  1. Kadokawa, T

    1. Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits.
      H Nakamura, Y Seto, S Motoyoshi, T Kadokawa and N Sunahara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 336-341;

  2. Kinter, L B

    1. SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).
      D P Brooks, P F Koster, C R Albrightson-Winslow, F L Stassen, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 211-215;

  3. Klinge, E

    1. Pharmacological analysis of nicotinic relaxation of bovine retractor penis muscle.
      E Klinge, S Alaranta and N O Sjöstrand
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 280-286;

  4. Kolm, P

    1. Endothelial regulation of cyclic GMP and vascular responses in hypertension.
      Y Shirasaki, P Kolm, G A Nickols and T J Lee
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 53-58;

  5. Kopin, I J

    1. Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 81-88;

  6. Koster, P F

    1. SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).
      D P Brooks, P F Koster, C R Albrightson-Winslow, F L Stassen, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 211-215;

  7. Kushiku, K

    1. Increment of calmodulin in proportion to enhancement of non-nicotinic responses after preganglionic stimulation of the dog cardiac sympathetic ganglia.
      K Kushiku, Y Araki, T Furukawa, T Iwasa, N Inoue and E Miyamoto
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 311-318;

L

  1. Latini, R

    1. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
      M C Gambino, S Passaghe, Z M Chen, F Bucchi, G Gori, R Latini, G de Gaetano and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 287-290;

  2. Lee, C O

    1. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity.
      D A Robertson, D Y Wang, C O Lee and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 124-128;

  3. Lee, T J

    1. Endothelial regulation of cyclic GMP and vascular responses in hypertension.
      Y Shirasaki, P Kolm, G A Nickols and T J Lee
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 53-58;

  4. Levi, R

    1. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity.
      D A Robertson, D Y Wang, C O Lee and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 124-128;

  5. Lis, E V

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

  6. Lohse, M

    1. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.
      J Scholz, B Schaefer, W Schmitz, H Scholz, M Steinfath, M Lohse, U Schwabe and J Puurunen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 327-335;

  7. Loomis, C W

    1. Tolerance to intrathecal oxymetazoline-induced analgesia, with paradigm-dependent cross-tolerance to intrathecal morphine.
      S E Sherman, C W Loomis, B Milne and F W Cervenko
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 319-326;

  8. Lotti, V J

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

  9. Lux, F

    1. Differential effects of subcutaneous and intrathecal morphine administration on blood glucose in mice: comparison with intracerebroventricular administration.
      F Lux, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 187-194;

M

  1. Mahacha, V

    1. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
      S M Pond, J A Waschek, V Mahacha, R M Fielding, D J Effeney and T N Tozer
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 291-293;

  2. Makhlouf, G M

    1. Identification of separate bombesin and substance P receptors on isolated muscle cells from canine gallbladder.
      C Severi, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 195-198;

  3. Malik, K U

    1. Prostaglandin synthesis elicited by cholinergic stimuli is mediated by activation of M2 muscarinic receptors in rabbit heart.
      N Jaiswal and K U Malik
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 59-66;

  4. Martin, W R

    1. Precipitation of abstinence in nordiazepam- and diazepam-dependent dogs.
      L F McNicholas, W R Martin, J W Sloan and E Wala
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 221-224;

  5. Mathiasen, J R

    1. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
      J L Vaught, J R Mathiasen and R B Raffa
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 13-16;

  6. McCabe, R T

    1. Osmotic shock: a method to eliminate endogenous gamma-aminobutyric acid and account for the influence on benzodiazepine binding affinity in autoradiographic studies.
      R T McCabe, R W Olsen, J P Yezuita and J K Wamsley
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 342-349;

  7. McElroy, J F

    1. Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement.
      J F McElroy and J M O'Donnell
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 155-163;

  8. McMillan, D E

    1. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
      G E Schulze, D E McMillan, J R Bailey, A Scallet, S F Ali, W Slikker and M G Paule
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 178-186;

  9. McNicholas, L F

    1. Precipitation of abstinence in nordiazepam- and diazepam-dependent dogs.
      L F McNicholas, W R Martin, J W Sloan and E Wala
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 221-224;

  10. Meisch, R A

    1. Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains.
      T Suzuki, F R George and R A Meisch
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 164-170;

  11. Milne, B

    1. Tolerance to intrathecal oxymetazoline-induced analgesia, with paradigm-dependent cross-tolerance to intrathecal morphine.
      S E Sherman, C W Loomis, B Milne and F W Cervenko
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 319-326;

  12. Milnor, W R

    1. Cholinergic receptors and contraction of smooth muscle in canine portal vein.
      W R Milnor and A Sastre
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 244-249;

  13. Miyamoto, E

    1. Increment of calmodulin in proportion to enhancement of non-nicotinic responses after preganglionic stimulation of the dog cardiac sympathetic ganglia.
      K Kushiku, Y Araki, T Furukawa, T Iwasa, N Inoue and E Miyamoto
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 311-318;

  14. Moore, R D

    1. 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase.
      B V Sastry, N Jaiswal, L K Owens, V E Janson and R D Moore
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 72-80;

  15. Morse, W H

    1. Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys.
      L L Howell, J Bergman and W H Morse
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 364-372;

  16. Mosberg, H I

    1. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
      J S Heyman, C L Williams, T F Burks, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 238-243;

  17. Motoyoshi, S

    1. Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits.
      H Nakamura, Y Seto, S Motoyoshi, T Kadokawa and N Sunahara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 336-341;

N

  1. Nakamura, H

    1. Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits.
      H Nakamura, Y Seto, S Motoyoshi, T Kadokawa and N Sunahara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 336-341;

  2. Narumiya, S

    1. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
      K Ohno, T Sakai, M Fukushima, S Narumiya and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 294-298;

  3. Nathanson, J A

    1. Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process.
      J A Nathanson
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 94-101;

  4. Nelson, S D

    1. Mechanism by which ethanol diminishes the hepatotoxicity of acetaminophen.
      K E Thummel, J T Slattery and S D Nelson
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 129-136;

  5. Nencini, P

    1. Sensitization to kappa opioid mechanisms associated with tolerance to the anorectic effects of cathinone.
      P Nencini, C E Johanson and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 147-154;

  6. Nickols, G A

    1. Endothelial regulation of cyclic GMP and vascular responses in hypertension.
      Y Shirasaki, P Kolm, G A Nickols and T J Lee
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 53-58;

  7. Nishiuchi, Y

    1. Mechanism of excitatory amino acid-induced accumulation of cyclic AMP in hippocampal slices: role of extracellular chloride.
      A Baba, Y Nishiuchi, A Uemura and H Iwata
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 299-304;

  8. Norman, W P

    1. Central nervous system site of action for the hypotensive effect of clonidine in the cat.
      P J Gatti, K J Hill, A M Da Silva, W P Norman and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 373-380;

O

  1. O'Donnell, J M

    1. Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement.
      J F McElroy and J M O'Donnell
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 155-163;

  2. Ohlstein, E H

    1. Relationship between LTD4-induced endothelium-dependent vasomotor relaxation and cGMP.
      R J Secrest, E H Ohlstein and B M Chapnick
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 47-52;

  3. Ohno, K

    1. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
      K Ohno, T Sakai, M Fukushima, S Narumiya and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 294-298;

  4. Olsen, R W

    1. Osmotic shock: a method to eliminate endogenous gamma-aminobutyric acid and account for the influence on benzodiazepine binding affinity in autoradiographic studies.
      R T McCabe, R W Olsen, J P Yezuita and J K Wamsley
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 342-349;

  5. Owens, L K

    1. 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase.
      B V Sastry, N Jaiswal, L K Owens, V E Janson and R D Moore
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 72-80;

P

  1. Parker, E M

    1. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
      E M Parker and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 199-210;

  2. Passaghe, S

    1. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
      M C Gambino, S Passaghe, Z M Chen, F Bucchi, G Gori, R Latini, G de Gaetano and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 287-290;

  3. Pasternak, G W

    1. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
      C L Williams, R J Bodnar, J E Clark, E F Hahn, T F Burks and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 8-12;

  4. Paule, M G

    1. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
      G E Schulze, D E McMillan, J R Bailey, A Scallet, S F Ali, W Slikker and M G Paule
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 178-186;

  5. Pentel, P

    1. Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning.
      M Callaham, H Schumaker and P Pentel
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 216-220;

  6. Pettibone, D J

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

  7. Phillips, E T

    1. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
      C J Helke and E T Phillips
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 41-46;

  8. Pond, S M

    1. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
      S M Pond, J A Waschek, V Mahacha, R M Fielding, D J Effeney and T N Tozer
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 291-293;

  9. Porreca, F

    1. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
      J S Heyman, C L Williams, T F Burks, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 238-243;

  10. Purdy, R E

    1. Further evidence for a homogeneous population of beta-1-adrenoceptors in bovine coronary artery.
      R E Purdy, G L Stupecky and P R Coulombe
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 67-71;

  11. Puurunen, J

    1. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.
      J Scholz, B Schaefer, W Schmitz, H Scholz, M Steinfath, M Lohse, U Schwabe and J Puurunen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 327-335;

R

  1. Raffa, R B

    1. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
      J L Vaught, J R Mathiasen and R B Raffa
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 13-16;

  2. Reisine, T

    1. Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population.
      T Reisine, H L Wang and S Guild
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 225-231;

  3. Reiss, D R

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

  4. Rimele, T J

    1. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.
      T J Rimele, R J Sturm, L M Adams, D E Henry, R J Heaslip, B M Weichman and D Grimes
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 102-111;

  5. Robertson, D A

    1. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity.
      D A Robertson, D Y Wang, C O Lee and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 124-128;

  6. Ropchak, T G

    1. Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 81-88;

  7. Rosen, M R

    1. Reduction of Vmax by QX-314 and benzocaine in neonatal and adult canine cardiac Purkinje fibers.
      W Spinelli, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 381-387;

S

  1. Sadée, W

    1. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.
      V C Yu and W Sadée
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 350-355;

  2. Sakai, T

    1. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
      K Ohno, T Sakai, M Fukushima, S Narumiya and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 294-298;

  3. Sastre, A

    1. Cholinergic receptors and contraction of smooth muscle in canine portal vein.
      W R Milnor and A Sastre
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 244-249;

  4. Sastry, B V

    1. 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase.
      B V Sastry, N Jaiswal, L K Owens, V E Janson and R D Moore
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 72-80;

  5. Scallet, A

    1. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
      G E Schulze, D E McMillan, J R Bailey, A Scallet, S F Ali, W Slikker and M G Paule
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 178-186;

  6. Schaefer, B

    1. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.
      J Scholz, B Schaefer, W Schmitz, H Scholz, M Steinfath, M Lohse, U Schwabe and J Puurunen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 327-335;

  7. Schmitz, W

    1. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.
      J Scholz, B Schaefer, W Schmitz, H Scholz, M Steinfath, M Lohse, U Schwabe and J Puurunen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 327-335;

  8. Scholz, H

    1. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.
      J Scholz, B Schaefer, W Schmitz, H Scholz, M Steinfath, M Lohse, U Schwabe and J Puurunen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 327-335;

  9. Scholz, J

    1. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.
      J Scholz, B Schaefer, W Schmitz, H Scholz, M Steinfath, M Lohse, U Schwabe and J Puurunen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 327-335;

  10. Schulze, G E

    1. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
      G E Schulze, D E McMillan, J R Bailey, A Scallet, S F Ali, W Slikker and M G Paule
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 178-186;

  11. Schumaker, H

    1. Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning.
      M Callaham, H Schumaker and P Pentel
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 216-220;

  12. Schuster, C R

    1. Sensitization to kappa opioid mechanisms associated with tolerance to the anorectic effects of cathinone.
      P Nencini, C E Johanson and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 147-154;

  13. Schwabe, U

    1. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.
      J Scholz, B Schaefer, W Schmitz, H Scholz, M Steinfath, M Lohse, U Schwabe and J Puurunen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 327-335;

  14. Schwartz, J S

    1. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
      R J Bache, D C Homans, J S Schwartz and X Z Dai
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 232-237;

  15. Secrest, R J

    1. Relationship between LTD4-induced endothelium-dependent vasomotor relaxation and cGMP.
      R J Secrest, E H Ohlstein and B M Chapnick
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 47-52;

  16. Seto, Y

    1. Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits.
      H Nakamura, Y Seto, S Motoyoshi, T Kadokawa and N Sunahara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 336-341;

  17. Severi, C

    1. Identification of separate bombesin and substance P receptors on isolated muscle cells from canine gallbladder.
      C Severi, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 195-198;

  18. Shear, N H

    1. Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells.
      J Uetrecht, N Zahid, N H Shear and W D Biggar
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 274-279;

  19. Sherman, S E

    1. Tolerance to intrathecal oxymetazoline-induced analgesia, with paradigm-dependent cross-tolerance to intrathecal morphine.
      S E Sherman, C W Loomis, B Milne and F W Cervenko
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 319-326;

  20. Shetty, S S

    1. Alterations in 28Mg distribution and movements in rabbit aortic smooth muscle.
      S S Shetty and G B Weiss
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 112-119;

  21. Shippenberg, T S

    1. Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine.
      M W Emmett-Oglesby, T S Shippenberg and A Herz
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 17-23;

  22. Shirasaki, Y

    1. Endothelial regulation of cyclic GMP and vascular responses in hypertension.
      Y Shirasaki, P Kolm, G A Nickols and T J Lee
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 53-58;

  23. Sjöstrand, N O

    1. Pharmacological analysis of nicotinic relaxation of bovine retractor penis muscle.
      E Klinge, S Alaranta and N O Sjöstrand
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 280-286;

  24. Slattery, J T

    1. Mechanism by which ethanol diminishes the hepatotoxicity of acetaminophen.
      K E Thummel, J T Slattery and S D Nelson
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 129-136;

  25. Slikker, W

    1. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
      G E Schulze, D E McMillan, J R Bailey, A Scallet, S F Ali, W Slikker and M G Paule
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 178-186;

  26. Sloan, J W

    1. Precipitation of abstinence in nordiazepam- and diazepam-dependent dogs.
      L F McNicholas, W R Martin, J W Sloan and E Wala
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 221-224;

  27. Spinelli, W

    1. Reduction of Vmax by QX-314 and benzocaine in neonatal and adult canine cardiac Purkinje fibers.
      W Spinelli, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 381-387;

  28. Stassen, F L

    1. SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).
      D P Brooks, P F Koster, C R Albrightson-Winslow, F L Stassen, W F Huffman and L B Kinter
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 211-215;

  29. Steinfath, M

    1. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.
      J Scholz, B Schaefer, W Schmitz, H Scholz, M Steinfath, M Lohse, U Schwabe and J Puurunen
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 327-335;

  30. Stitzel, R E

    1. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats.
      S J Donohue, R E Stitzel and R J Head
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 24-31;

  31. Stupecky, G L

    1. Further evidence for a homogeneous population of beta-1-adrenoceptors in bovine coronary artery.
      R E Purdy, G L Stupecky and P R Coulombe
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 67-71;

  32. Sturm, R J

    1. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.
      T J Rimele, R J Sturm, L M Adams, D E Henry, R J Heaslip, B M Weichman and D Grimes
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 102-111;

  33. Sun, G Y

    1. Alterations in rat brain polyphosphoinositide metabolism due to acute ethanol administration.
      R Chandrasekhar, H M Huang and G Y Sun
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 120-123;

  34. Sunahara, N

    1. Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits.
      H Nakamura, Y Seto, S Motoyoshi, T Kadokawa and N Sunahara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 336-341;

  35. Suzuki, T

    1. Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains.
      T Suzuki, F R George and R A Meisch
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 164-170;

  36. Sweeney, B M

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

T

  1. Tanaka, C

    1. Benzodiazepines and barbiturate potentiate the pre- and postsynaptic gamma-aminobutyric acid (GABA)A receptor-mediated response in the enteric nervous system of guinea pig small intestine.
      K Taniyama, S Hashimoto, S Hanada and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 250-256;

  2. Tanda, G

    1. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
      A Imperato, G Tanda, R Frau and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 257-264;

  3. Taniyama, K

    1. Benzodiazepines and barbiturate potentiate the pre- and postsynaptic gamma-aminobutyric acid (GABA)A receptor-mediated response in the enteric nervous system of guinea pig small intestine.
      K Taniyama, S Hashimoto, S Hanada and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 250-256;

  4. Thummel, K E

    1. Mechanism by which ethanol diminishes the hepatotoxicity of acetaminophen.
      K E Thummel, J T Slattery and S D Nelson
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 129-136;

  5. Tozer, T N

    1. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
      S M Pond, J A Waschek, V Mahacha, R M Fielding, D J Effeney and T N Tozer
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 291-293;

U

  1. Uemura, A

    1. Mechanism of excitatory amino acid-induced accumulation of cyclic AMP in hippocampal slices: role of extracellular chloride.
      A Baba, Y Nishiuchi, A Uemura and H Iwata
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 299-304;

  2. Uetrecht, J

    1. Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells.
      J Uetrecht, N Zahid, N H Shear and W D Biggar
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 274-279;

V

  1. Vacca, J

    1. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
      B V Clineschmidt, D J Pettibone, V J Lotti, H B Hucker, B M Sweeney, D R Reiss, E V Lis, J R Huff and J Vacca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 32-40;

  2. Vanhoutte, P M

    1. Cooling the central ear artery of the rabbit: myogenic and adrenergic responses.
      C T Harker and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 89-93;

  3. Vaught, J L

    1. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
      J L Vaught, J R Mathiasen and R B Raffa
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 13-16;

W

  1. Wala, E

    1. Precipitation of abstinence in nordiazepam- and diazepam-dependent dogs.
      L F McNicholas, W R Martin, J W Sloan and E Wala
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 221-224;

  2. Wamsley, J K

    1. Osmotic shock: a method to eliminate endogenous gamma-aminobutyric acid and account for the influence on benzodiazepine binding affinity in autoradiographic studies.
      R T McCabe, R W Olsen, J P Yezuita and J K Wamsley
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 342-349;

  3. Wang, D Y

    1. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity.
      D A Robertson, D Y Wang, C O Lee and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 124-128;

  4. Wang, H L

    1. Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population.
      T Reisine, H L Wang and S Guild
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 225-231;

  5. Waschek, J A

    1. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
      S M Pond, J A Waschek, V Mahacha, R M Fielding, D J Effeney and T N Tozer
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 291-293;

  6. Weichman, B M

    1. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.
      T J Rimele, R J Sturm, L M Adams, D E Henry, R J Heaslip, B M Weichman and D Grimes
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 102-111;

  7. Weiss, G B

    1. Alterations in 28Mg distribution and movements in rabbit aortic smooth muscle.
      S S Shetty and G B Weiss
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 112-119;

  8. Williams, C L

    1. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
      J S Heyman, C L Williams, T F Burks, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 238-243;
    2. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
      C L Williams, R J Bodnar, J E Clark, E F Hahn, T F Burks and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 8-12;

Y

  1. Yezuita, J P

    1. Osmotic shock: a method to eliminate endogenous gamma-aminobutyric acid and account for the influence on benzodiazepine binding affinity in autoradiographic studies.
      R T McCabe, R W Olsen, J P Yezuita and J K Wamsley
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 342-349;

  2. Yu, V C

    1. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.
      V C Yu and W Sadée
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 350-355;

Z

  1. Zahid, N

    1. Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells.
      J Uetrecht, N Zahid, N H Shear and W D Biggar
      Journal of Pharmacology and Experimental Therapeutics April 1988, 245 (1) 274-279;
Back to top

In this issue